Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stereotaxis Inc (STXS)

Stereotaxis Inc (STXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 170,245
  • Shares Outstanding, K 82,643
  • Annual Sales, $ 26,770 K
  • Annual Income, $ -20,710 K
  • 60-Month Beta 1.52
  • Price/Sales 6.30
  • Price/Cash Flow N/A
  • Price/Book 11.61
Trade STXS with:

Options Overview Details

View History
  • Implied Volatility 135.38% ( -3.15%)
  • Historical Volatility 40.61%
  • IV Percentile 60%
  • IV Rank 15.45%
  • IV High 651.57% on 06/12/24
  • IV Low 41.06% on 06/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 50
  • Volume Avg (30-Day) 87
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 8,494
  • Open Int (30-Day) 8,015

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.04
  • Number of Estimates 3
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.71 +20.47%
on 06/28/24
2.13 -3.06%
on 07/17/24
+0.33 (+19.08%)
since 06/26/24
3-Month
1.66 +24.10%
on 06/26/24
2.48 -16.93%
on 05/03/24
-0.24 (-10.43%)
since 04/26/24
52-Week
1.33 +54.89%
on 08/08/23
3.29 -37.39%
on 04/05/24
+0.57 (+38.26%)
since 07/26/23

Most Recent Stories

More News
Stereotaxis (STXS) Q2 2022 Earnings Call Transcript

STXS earnings call for the period ending June 30, 2022.

STXS : 2.06 (+0.98%)
Stereotaxis Reports 2022 Second Quarter Financial Results

ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.06 (+0.98%)
Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline

ST. LOUIS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.06 (+0.98%)
Stereotaxis to Report Second Quarter Financial Results on August 9, 2022

ST. LOUIS, July 19, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.06 (+0.98%)
Stereotaxis Announces CE Mark Submission for Robotically Navigated MAGiC Ablation Catheter

ST. LOUIS, July 11, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.06 (+0.98%)
Journal of Atrial Fibrillation & Electrophysiology Publishes Special Issue Dedicated to Robotics in EP

16 Peer-Reviewed Publications Highlight Clinical Value of Robotic Magnetic Navigation for Heart Rhythm Disorders...

STXS : 2.06 (+0.98%)
Stereotaxis (STXS) Q1 2022 Earnings Call Transcript

STXS earnings call for the period ending March 31, 2022.

STXS : 2.06 (+0.98%)
Stereotaxis Reports 2022 First Quarter Financial Results

ST. LOUIS, May 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.06 (+0.98%)
Heart Centre Rigshospitalet Copenhagen Celebrates 5,000 Robotic Cardiac Ablation Procedures

Denmark’s only robotic cardiac electrophysiology team is recognized for leading the world in treating the most heart rhythm patients using Stereotaxis’...

STXS : 2.06 (+0.98%)
National Institute of Cardiology Becomes First Hospital in Poland to Establish Advanced Robotic Program to Treat Heart Rhythm Disorders

Stereotaxis robotic technology now in use in 25 countries...

STXS : 2.06 (+0.98%)

Business Summary

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires...

See More

Key Turning Points

3rd Resistance Point 2.17
2nd Resistance Point 2.11
1st Resistance Point 2.09
Last Price 2.06
1st Support Level 2.01
2nd Support Level 1.95
3rd Support Level 1.93

See More

52-Week High 3.29
Fibonacci 61.8% 2.54
Fibonacci 50% 2.31
Fibonacci 38.2% 2.08
Last Price 2.06
52-Week Low 1.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar